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Levels of1 acid glycoprotein and ceruloplasmin predict future A low serum albumin is closely associated with the ex-
albumin levels in hemodialysis patients. cessive mortality of hemodialysis (HD) [1, 2]. The associ-
Background. Serum albumin concentration predicts mortal- ation has been attributed to consequences of malnutri-ity in hemodialysis (HD) patients. While serum albumin con-
tion [3] and/or inflammation [4, 5]. However, the principalcentration correlates with serum concentration of C-reactive
cause of death in hemodialysis patients is cardiovascularprotein (CRP) and is dependent upon CRP in multiple regres-
sion models in cross sectional studies, CRP does not predict [6]. Interestingly, inflammation also has been identified
future albumin levels, possibly because CRP changes rapidly, as an epidemiologically important risk factor for cardio-
yielding large month-to-month variability in CRP. If inflam-
vascular disease in the general population [7–11].mation causes rather than is simply associated with hypoalbum-
In multiple regression analysis, inclusion of C-reactiveinemia, then changes in the levels of acute phase proteins
should precede changes in serum albumin concentration. protein (CRP) [5, 12] or interleukin-6 (IL-6) [5] reduced
Methods. The levels of long-lived positive and negative acute- or eliminated the predictive value of albumin on survival,
phase proteins (APPs) (C-reactive protein, ceruloplasmin, 1 suggesting that inflammation was responsible for the pre-acid glycoprotein, transferrin and albumin) were measured lon-
dictive effect of albumin on mortality, including cardio-gitudinally in 64 HD patients and a regression model was con-
vascular mortality. It must be emphasized, however, thatstructed to predict future albumin levels. Normalized protein
catabolic rate (nPCR) was measured monthly. The number of associations cannot define a cause-effect relationship. In
repeated measurements ranged from 9 to 39 in each patient fact, a longitudinal study observed that while CRP corre-
(median 22 and a mean of 23 measurements). To construct a
lated inversely with the current albumin level, it did notmodel that would predict serum albumin concentration at any
predict future serum albumin levels, possibly becausetime j, values of all longitudinally measured APPs, positive
and negative at any time j  1, approximately 30 days prior CRP changed so rapidly (half-life 19 hours [13]) that a
to time j, were used. Other demographic factors (such as, race, time relationship between serum CRP and albumin was
access type, and cause of renal failure) also were incorporated obscured [14, 15]. It also is possible that very acute in-into the model.
flammatory events might have time to resolve prior toResults. The model with the best fit for predicting serum
the subsequent measurement of albumin, approximatelyalbumin at time j included albumin, ceruloplasmin, and 1 acid
glycoprotein measured at time j  1. The only demographic a month later.
variable with subsequent predictive value was diabetes. The goal of this study was to establish whether changes
Conclusions. The finding that changes in the concentration
in the levels of acute phase proteins having longer half-of the long lived APPs measured one month earlier are associ-
lives than CRP would predict future serum albumin lev-ated with predictable changes in the future concentration of
serum albumin suggest that changes in inflammation are likely els. Alpha-1 acid glycoprotein (1 AG) has a half-life
to be causal in determining serum albumin concentration in of approximately 65 hours [15] and ceruloplasmin has a
hemodialysis patients.
fractional catabolic rate of 16.6  2.3 percent of the
plasma pool per day corresponding to a half-life of ap-
proximately three days [16]. It was reasoned that if in-Key words: inflammation, hypoalbuminemia, hemodialysis, C reactive
protein, acute phase proteins. flammation increased in production of acute phase pro-
teins and caused lower values of serum albumin, markers
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might have a greater predictive value on future serum protein catabolic rate (nPCR) also was measured monthly
but it is not an outcome variable for the HEMO Study,albumin levels compared to more rapidly changing pro-
teins (such as CRP) or cytokines. A linear prediction model so the predictive effect of nPCR on future albumin con-
centrations was analyzed.with variable selection to assess the actual predictive value
of both short- and long-lived APPs was developed.
Laboratory methods
Albumin was measured in duplicate using bromcresol
METHODS
green. All other proteins were measured with rate nephe-
Patient selection lometry using a Beckman Array automated nephelome-
ter (Beckman Instruments, Fullerton, CA, USA) [17].The individual Institutional Review Boards at each
institution approved the protocol and informed consent All nephelometric measurements were made in dupli-
cate in each of two optical systems. The average of thesewas obtained from each patient. Sixty-four patients en-
rolled in the National Institutes of Health HEMO Study values was used for calculations. The intra-assay coeffi-
cient of variation for albumin was 0.22%, with an inter-at the University of California Davis in Sacramento,
California, at Beth Israel Medical Center in New York, assay coefficient of variation ranging from 2.42% to
3.16%. The intra-assay coefficient of variation for 1New York, and at Emory University in Atlanta, Georgia
were recruited to participate in this longitudinal study. AG was 0.14%, with an interassay coefficient of variation
ranging from 3.07% to 5.50%. The intra-assay coefficientDuring the first six weeks serum concentrations of CRP,
albumin, transferrin, 1 AG and ceruloplasmin were of variation for ceruloplasmin was 0.27. The intra-assay
coefficient of variation for transferrin ranged from 0.026%measured weekly. Subsequently, each protein was mea-
sured monthly on serum obtained from pre-dialysis sam- to 0.07%, with an interassay coefficient of variation rang-
ing from 2.56% to 4.38%.ples. The 64 patients had been on dialysis for a mean
time of 6.44  3.45 years (1.32 to 21.56 years; median Samples were frozen initially on dry ice and then
stored at 20C until assay. Biochemical assays were6.40 years; 25th percentile, 3.73 years and 75th percentile,
7.68 years). Median age was 58.5 years (range 19 to 81 performed once a week on samples received during that
week in a central laboratory (Davis, CA, USA).years; 25th percentile, 49.5 and 75th percentile, 69 years)
Body mass index was 23.705  4.445 kg/m2. Twenty- The means for each value were calculated by first
calculating the means within subjects, then taking theseven patients were women and 37 were men. Thirty-
two patients were African American, and 38 patients means of these means. The standard deviations were
calculated by generating the standard deviations withinhad diabetes mellitus. Renal failure was caused by hyper-
tension in 14 patients, 9 patients had glomerulonephritis, subjects, and then taking the mean of these standard
deviations.2 had adult polycystic kidney disease, one had systemic
lupus, one had chronic pyelonephritis, one had acute
Statistical analysis for predictingrenal failure, one had analgesic nephropathy one had
albumin concentrationnephrectomy secondary to renal cell carcinoma and the
remainder had renal failure of uncertain etiology. Thirty- The goal was to obtain the best fitting model for pre-
dicting serum albumin concentration at any arbitrary timeone patients had a subcutaneous polytetrafluoraethylene
(PTFE; Gortex) graft, 25 had arteriovenous (AV) fistulas j by using a longitudinal, mixed-effects linear model [18].
The times of measurements were labeled as 1, 2, . . ., j and eight had a semipermanent transcutaneous access
(Permcath). 1, j, j  1, . . . and the measurement at time j  1 was
one month prior to that at time j.Nine patients were dialyzed using a F80 B (Fresenius
Medical Care AG, Bad Homburg Germany), 12 with a The possible predictors included demographic vari-
ables (sex, age, race), patient characteristics (time onF80 A, 26 using a F 8 (Fresenius Medical Care AG) one
with a F 6 (Fresenius Medical Care AG) 5 using a CA210 dialysis, and the cause of renal failure as diabetic or
non-diabetic) and the most recent measurements of alldialyzer (Baxter Healthcare Corporation, Deerfield, IL,
USA), 7 using a CT190G dialyzer (Baxter Healthcare longitudinally measured acute phase proteins, (CRP, ce-
ruloplasmin, 1 AG and transferrin) obtained at theCorporation), 3 using CT 190, (Baxter Healthcare Cor-
poration) dialyzer. One patient was dialyzed with a Fil- previous measurement time j 1, approximately 30 days
earlier. The time interval used for prediction was approx-tral 20 dialyzer (Hospal, Boca Raton, FL, USA). All dial-
ysis was performed using bicarbonate-based dialysate at imately 30 days prior to the time of the predicted albumin
concentration at current time j. The variable selectiona delivered bicarbonate concentration of 39 mEq/L.
The Kt/V was measured monthly but these data were method was used to find the set of most pertinent pre-
dictors among these variables. This model was con-not included in the analysis, since they are required for
the randomization of the HEMO Study and investigators structed by using a forward variable selection procedure
with Akaike’s information criterion (AIC) criterion [19].are currently blinded to that parameter. The normalized
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Table 1. Means and standard deviations for the proteins and normalized protein catabolic rate (nPCR) for all values during the time period
used for calculation of the effects of acute-phase proteins on future albumin concentrations
CRP 1 AG Ceruloplasmin Transferrin
Albumin nPCR
g/dL mg/dL g
4.110.26 1.251.53 120.4924.08 40.226.67 175.9421.27 0.9760.122
The means for each parameter were calculated by first calculating means for each subject The means of mean values were then calculated. The standard deviations
were calculated by generating the standard deviations within subjects, then taking the mean of these standard deviations.
Table 2. Model that most closely predicts serum albuminThe number of repeated measurements ranged from 9
concentration at time j using measurements of serum proteins at
to 39 in each patient (median 22 measurements). prior time j  1 and initial demographic and disease-specific variables
Statistical analysis was performed using the statistical
Variable Estimate SEM z ratio P valuesoftware package S-Plus, version 4.5 using the linear
Intercept 2.9195 0.1783mixed effects model function
Albumin at j  1 0.3693 0.0376 9.8125 0.0001
Since CRP predicts contemporaneous albumin values Ceruloplasmin at j  1 0.0043 0.0015 2.8396 0.0045
1 AG at j  1 0.0010 0.0003 2.8336 0.0046in cross sectional studies, but not future albumin levels
Diabetes 0.0918 0.0366 2.5085 0.0121[14], we reasoned that whatever physiologic factors es-
The best-fitting prediction model for albumin in 64 hemodialysis patients intablish CRP levels may interact with serum albumin con-
whom between 9 and 39 sequential measurements of albumin and acute phase
centration in a different way than do those factors that proteins were made using a longitudinal mixed effects linear model. The possible
predictors included demographic variables, patient characteristics and the mostexert their effects in the future. In order to test this
recent previous measurements of all longitudinally measured acute phase pro-
hypothesis, we performed additional analysis in which teins and nPCR. The proteins included C-reactive protein (CRP), ceruloplasmin,
1 acid glycoprotein (1 AG) and transferrin. This time used for prediction wascurrent levels of CRP were introduced (at time j) to
approximately one month prior to the time of the predicted albumin concentra-
establish (1) whether the effect of CRP on albumin con- tion at future time j.
centration at time j was still evident) and (2) to establish
whether the addition of CRP changed the relationships
between terms that predicted future albumin levels (that
that both 1 AG and ceruloplasmin were found to beis, 1 AG at time j  1, ceruloplasmin at time j  1 and
additional significant predictors in a model, which al-albumin at time j  1).
ready contained the previous albumin concentration as
a predictor (Table 2).
RESULTS Ethnicity (black vs. non-black), gender, age, body
mass index, and vascular access type had no significantSerum albumin values in individual patients varied
effect on serum albumin concentration. We cannot ex-over time as previously observed [14]. The mean and
clude the possibility that this lack of an effect may reflectstandard deviation of the mean value for each protein
an insufficient number of patients in the study. The onlyduring this time interval is provided in Table 1.
demographic variable that had an effect on serum albu-By far the best single predictor for the current serum
min concentration was the presence or absence of diabe-albumin was its previous concentration. This result is
tes, which was associated with lower serum albumin con-not surprising because the albumin pool is large (350
centration.g/1.73 m2) and turns over slowly (half-life from 14 to 21
As expected, the signs of the parameter estimates fordays) [20–24].
ceruloplasmin at j  1, 1 AG at j  1 and disorderConsequently, changes in either the synthesis or catab-
(presence of diabetes) are all negative, while the sign ofolism of albumin are reflected only slowly in the serum
the parameter estimate for albumin at j  1 is positive.albumin concentration (that is, the changes are well buf-
Hence, the best model to predict albumin at time j in-fered). Besides the prior albumin value, the current albu-
cluded albumin concentration at time j  1, ceruloplas-min concentration at any time can be predicted by the
min concentration at time j 1, and 1 acid glycoproteinconcentration of both 1 AG and by ceruloplasmin mea-
concentration j  1, as well as the presence of diabetes.sured at approximately one month prior to the predicted
The results in Figure 1 show the longitudinal relation-value. The levels of other positive or negative acute
ships between prior measurements of serum ceruloplas-phase proteins did not improve the association between
min, 1 AG and the current value of serum albumin inserum ceruloplasmin or 1 AG and serum albumin. Spe-
four randomly selected patients; the predicted serumcifically, levels of CRP or transferrin had no value in
albumin concentration also is presented. To simplify thepredicting future serum albumin concentration even
presentation, earlier values of serum albumin were notthough the two proteins correlated with contemporane-
ous serum albumin levels (Table 3). It is noteworthy included (even though they are included in the final
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Fig. 1. Temporal relationship between ob-
served () and predicted () serum albumin
concentration (g/dL) measured or predicted at
time j and the concentration of ceruloplasmin
() (mg/dL) and 1 acid glycoprotein ()
(mg/dL) measured at time j  1, approxi-
mately a month before time j in 4 patients on
chronic hemodialysis, chosen from a total of
64 such patients.
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Table 3. Model that most closely predicts serum albumin
concentration at time j using measurements of serum proteins at
prior time j  1 and initial demographic and disease-specific variables
with the addition of CRP at time j
Variable Estimate SEM z ratio P value
(Intercept) 2.998301 0.173285 17.3027 —
Albumin at j  1 0.34821 0.038013 9.1602 0.0001
Ceruloplasmin at j  1 0.0034 0.001092 3.1133 0.0019
1 AG at j  1 0.00073 0.000282 2.576 0.01
Diabetes 0.09001 0.038487 2.3387 0.0194
CRP at j 0.04148 0.005686 7.2958 0.0001
The effect of addition of current CRP values (at time j) on the ability of
prediction of current serum albumin concentration (at time j) by the concentra-
tions of both albumin and long-lived acute phase proteins occurring approxi-
mately a month earlier (at time j  1). Note that while CRP at time j  1 had
no predictive effect on future serum albumin concentration, CRP at time j had
a powerful effect on controlling current serum albumin concentration while not
in any way disrupting the effects of earlier events.
Fig. 2. Observed versus predicted serum albumin concentration for
the entire data array.
DISCUSSION
Serum albumin level is controlled by nutritional fac-
prediction model). Each panel includes an insert showing tors [25–28], external loss [29], inflammation [30, 31],
the relationship between serum protein concentrations and by changes in its distribution volume. In earlier re-
at times j and j 1. It is apparent that there is an inverse ports, we found that a short lived marker of inflammation
(CRP level) was the factor most closely correlated withor reciprocal relationship between the serum concentra-
current serum albumin in both cross sectional [32] andtions of the positive acute-phase proteins at time j  1,
longitudinal studies [14] of maintenance hemodialysisand that of the predicted and observed albumin level at
patients. Both albumin and CRP decreased and in-the at subsequent time, j. Secondly, the predicted serum
creased continuously with one another during the longi-albumin concentration closely parallels the observed se-
tudinal study [14], so the level of CRP was not useful inrum albumin concentration in individual series and when
predicting serum albumin at the time of the next mea-all of the data are combined (Fig. 2), the predicted and
surement approximately a month later. But correlationsobserved values agree closely. The combination of all
between variables in a cross-sectional analysis cannot
three longitudinal predictors, plus the diabetes status, alone infer causality. Partial data from the first 37 of
produces the least scatter around the regression relating these patients were analyzed and reported previously
observed and predicted values. It should be noted that [14]. The time of observation on these same patients has
the observations in this scatter-plot are not independent been extended here and combined with data from the
observations, (they include all repeated measurements) additional patients. Despite the increase in time of obser-
so no regression line has been plotted for these data. vation and the number of patients the observations that
When CRP at time j was added to the model it had we reported previously persist. CRP continues to corre-
late with contemporaneous values of serum albumin butan additive and highly significant effect (Table 3) on
cannot predict future albumin values. Additionally, thedescribing current albumin (at time j). More importantly,
model used for analysis in the current study was differentthe coefficients and the significance of the other variables
than that done from that used previously, allowing us toat time j  1 were unchanged when CRP at time j was
focus on prediction of future albumin.added. This suggests that CRP controls albumin concen-
None of the lagged predictors were of additional valuetration by a separate mechanism than do events control-
in the previous study [14] because current predictors wereling serum albumin, ceruloplasmin, 1 AG (all at time
included at all time points. The lagged predictors thenj  1) and the presence of diabetes.
did not add significant prediction value. In the present
Adding nPCR at j1 to the final model that already study, we only allow lagged predictors, assuming none
includes albumin at j  1, ceruloplasmin at j  1, 1 of the current values were available. The aim therefore
AG j  1 and disorder (presence of diabetes) does not was a real prediction of future measurements from the
improve the model. The individual variable nPCR at j values. Our present findings offer more compelling evi-
1 had a positive coefficient (as expected) but was not dence for a cause and effect relationship between in-
significant, with a P value of 0.1878. Including nPCR at flammation and hypoalbuminemia since changes in both
j  1 in the final model does not affect the significance ceruloplasmin and 1 AG clearly precede the change in
albumin concentration. As expected, serum albumin atof the other variables.
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any given time exerted a powerful effect on future values proteins, such as ceruloplasmin and 1 AG are found.
Inflammation precedes and likely causes changes in albu-because the pool of albumin is large [33, 34] and its rate
of catabolism low. min concentration in dialysis patients.
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